Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns

Keiji Yamana, Ichiro Morioka, Daisuke Kurokawa, Sachiyo Fukushima, Kosuke Nishida, Shohei Ohyama, Noriyuki Nishimura, Kandai Nozu, Mariko Taniguchi-Ikeda, Hiroaki Nagase, Kazumichi Fujioka, Sota Iwatani, Hajime Nakamura, Kazumoto Iijima

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Non-invasive transcutaneous bilirubin (TcB) monitoring has been widely used to screen for hyperbilirubinemia. TcB measured using the recently developed BiliCare™ system, however, has not been fully evaluated. Methods: One hundred and seven TcB measurements were obtained from 82 Japanese newborns ≥35 weeks’ gestational age within 2 weeks after birth. Measurements were taken at the scaphoid fossa, conchal cavity, and lobe of the ear using BiliCare. BiliCare TcB were compared with total serum bilirubin (TB) and TcB obtained using another bilirubinometer (JM-105™). Results: Transcutaneous bilirubin measured at all three sites significantly correlated with TB (r = 0.91, 0.93, and 0.93 at the scaphoid fossa, conchal cavity, and lobe, respectively). The mean differences were 0.1, −0.3, and 3.6 at the scaphoid fossa, conchal cavity, and lobe, respectively. BiliCare TcB at the scaphoid fossa significantly correlated with that using the JM-105 (r = 0.91). The mean difference was 0.0. BiliCare, however, produced a significantly higher and lower TcB than the JM-105 for TB <7 and ≥15 mg/dL, respectively. Conclusions: Transcutaneous bilirubin measurements taken at the scaphoid fossa or conchal cavity using BiliCare were more reliable than those at the earlobe. BiliCare TcB differed from those of the JM-105, for TB <7 or ≥15 mg/dL.

Original languageEnglish
Pages (from-to)1058-1063
Number of pages6
JournalPediatrics International
Volume59
Issue number10
DOIs
Publication statusPublished - 10-2017

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns'. Together they form a unique fingerprint.

  • Cite this

    Yamana, K., Morioka, I., Kurokawa, D., Fukushima, S., Nishida, K., Ohyama, S., Nishimura, N., Nozu, K., Taniguchi-Ikeda, M., Nagase, H., Fujioka, K., Iwatani, S., Nakamura, H., & Iijima, K. (2017). Evaluation of BiliCare™ transcutaneous bilirubin device in Japanese newborns. Pediatrics International, 59(10), 1058-1063. https://doi.org/10.1111/ped.13364